The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens

Current Topics in Microbiology and Immunology

Volumn 319, Issue , 2008, Pages 17-40

  Mond, J J ^a   Kokai Kun, J F ^a  

^a Biosynexus Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

13VPNC; BACTERIAL VACCINE; BSYX A110; GLOBORIX; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENAETRA; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE; SALMONELLOSIS VACCINE; STAPHYLOCOCCUS VACCINE; STREPTOCOCCUS VACCINE; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE ANTIGEN; TOLL LIKE RECEPTOR; TYPHOID VACCINE; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; THYMUS INDEPENDENT ANTIGEN; VACCINE;

ANTIBODY RESPONSE; ANTIGEN RECOGNITION; B LYMPHOCYTE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA TYPHI; SALMONELLOSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE; VACCINATION; ANIMAL; BIOSYNTHESIS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY;

BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE; NEISSERIA MENINGITIDIS; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTIGENS, T-INDEPENDENT; BACTERIAL VACCINES; HUMANS; POLYSACCHARIDES, BACTERIAL; VACCINES, CONJUGATE;

EID: 38449094767     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-73900-5_2     Document Type: Review

References (95)

1. Ahmad A, Mond JJ (1986) Restoration of in vitro responsiveness of xid B cells to TNP-Ficoll by 8-mercaptoguanosine. J Immunol 136:1223-1226
2. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, Taniguchi M, Grusby MJ, DeKruyff RH, Umetsu DT (2003) Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperactivity. Nat Med 9:582-588
3. AlonsoDeVelasco E, Verheul AF, Verhoef J, Snippe H (1995) Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol Rev 59:591-603
4. Balazs M, Martin F, Zhou T, Kearney JF (2002) Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17:341-352
5. Barenkamp SJ (2004) Rationale and prospects for a nontypable Haemophilus influenzae vaccine. Pediatr Infect Dis J 23:461-462
6. Baril L, Dietemann J, Essevaz-Roulet M, Beniguel L, Coan P, Briles DE, Guy B, Cozon G (2006) Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults. Clin Exp Immunol 145:277-286
7. Baxter-Healthcare-Australia (2003) NeisVac-C™ Vaccine. Consumer Medicine Information, NeisVac-C
8. Blery M, Tze L, Miosge LA, Jun JE, Goodnow CC (2006) Essential role of membrane cholesterol in accelerated BCR internalization and uncoupling from NF-kappa B in B cell clonal anergy. J Exp Med 203:1773-1783
9. Bogaert D, Hermans PWM, Padrian PV, Rumke HC, de Groot R (2004) Pneumococcal vaccines: an update on current strategies. Vaccine 22:2209-2220
10. Bohach GA, Foster TJ (2000) Staphylococcus aureus exotoxins. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI (eds) Gram-positive pathogens. ASM Press, Washington DC, pp 367-378
11. Boswell CM, Stein KE (1996) Avidity maturation, repertoire shift, and strain differences in antibodies to bacterial levan, a type 2 thymus-independent polysaccharide antigen. J Immunol 157:1996-2005
12. Briles DE, Patton JC, Swialto E, Nahm MH (2000) Pneumococcal vaccines. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI (eds) Gram-positive pathogens. ASM Press, Washington DC, pp 244-250
13. Brunswick M, Finkelman FD, Highet PF, Inman JK, Dintzis HM, Mond JJ (1988) Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation. J Immunol 140:3364-3372
14. Brunswick M, June CH, Finkelman FD, Dintzis HM, Inman JK, Mond JJ (1989) Surface Ig-mediated B cell activation in the absence of detectable elevations in intracellular ionized calcium: a model for T-cell-independent B-cell activation. Proc Natl Acad Sci U S A 86:6724-6728
15. Cartwright KA (1999) Neisseria meningitidis. In: Yu VL, Merigan TC, Barriere SL (eds) Antimicrobial Therapy and Vaccines. Williams & Wilkins, Baltimore, pp 303-309
16. Casal J, Tarrago D (2003) Immunity to Streptococcus pneumoniae: factors affecting production and efficacy. Curr Opin Infect Dis 16:219-224
17. Chen Q, Sen G, Snapper CM (2006) Endogenous IL-1R1 signaling is critical for cognate CD4+ cell help for introduction of in vivo type 1 and type 2 antipolysaccharide and antiprotein Ig isotype responses to intact Streptococcus pneumoniae but not to a soluble pneumococcal conjugate vaccine. J Immunol 177:6044-6051
18. Colino J, Shen Y, Snapper CM (2002) Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms. J Exp Med 195:1-13
19. Danzig L (2004) Meningococcal vaccines. Pediatr Infect Dis J 23:S285-S292
20. Dempsey PW, Allison ME, Akaraju S, Goodenow C, Fearon DT (1996) C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348-350
21. Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167-193
22. Donnelly JJ, Deck RR, Liu MA (1990) Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine. J Immunol 145:3071-3079
23. Fattom AI, Horwith G, Fuller S, Propst M, Naso R (2004) Development of StaphVAX®, a polysaccharide conjugate vaccine against S. aureus infection: from lab bench to phase III clinical trials. Vaccine 22:880-887
24. Fischer W (1994) Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus. Med Microbiol Immunol 183:61-76
25. Fuentes-Panana EM, Bannish G, Monroe JG (2004) Basal B-cell receptor signaling in B lymphocytes: mechanisms of regulation and role in positive selection, differentiation, and peripheral survival. Immunol Rev 197:26-40
26. Gavin AL, Hoebe K, Duong B, Ota T, Martin C, Beutler B, Nemazee D (2006) Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314:1936-1938
27. Girard MP, Preziosi MP, Aguado MT, Kieny MP (2006) A review of vaccine research and development: Meningococcal disease. Vaccine 24:4692-4700
28. GlaxoSmithKline (2002a) ACWY Vax® Meningococcal Polysaccharide Vaccine PhEur. Patient information leaflet, 45393
29. GlaxoSmithKline (2002b) Typherix VI® polysaccharide typhoid vaccine. Patient information leaflet, 3153
30. GlaxoSmithKline (2004) Hiberix® Haemophilus influenza type b (Hib) Vaccine. Patient information leaflet, 407575
31. Golding H, Foiles PG, Rittenberg MB (1982) Partial reconstitution of TNP-Ficoll responses and IgG3 expression in Xid mice undergoing graft-vs-host reaction. J Immunol 129:2641-2646
32. Hayakawa K, Hardy RR (2000) Development and function of B-1 Cells. Curr Opin Immunol 12:346-353
33. Hayward AR, Lawton AR (1977) Induction of plasma cell differentiation of human fetal lymphocytes: evidence for functional immaturity of T and B cells. J Immunol 119: 1213-1217
34. Herbert MA, Moxon ER (1999) Haemophilus influenzae. In: Yu VL, Merigan TC, Barriere SL (eds) Antimicrobial therapy and vaccines. Williams & Wilkins, Baltimore. pp 213-227
35. Karnell FG, Brezski RJ, King LB, Silverman MA, Monroe JG (2005) Membrane cholesterol content accounts for developmental differences in surface B cell receptor compartmentalization and signaling. J Biol Chem 280:25621-25628
36. Kelly DF, Moxon ER, Pollard AJ (2004) Haemophilus influenzae type b conjugate vaccines. Immunol 113:163-174
37. Khan AQ, Shen Y, Wu ZQ, Wynn TA, Snapper CM (2002) Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect Immun 70:749-761
38. Khan AQ, Chen Q, Wu ZQ, Paton JC, Snapper CM (2005) Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2. Infect Immun 73:298-307
39. Khan WN, Alt FW, Gerstein RM, Malynn BA, Larsson I, Rathbun G, Davidson L, Muller S, Kantor AB, Herzenberg LA, Rosen FS, Sideras P (1995) Defective B cell development and function in Btk-deficient mice. Immunity 3:283-299
40. Koedel U, Angele B, Rupprecht T, Wagner H, Roggenkamp A, Pfister H-W, Kirschning CJ (2003) Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J Infect Dis 186:798-806
41. Konigshofer Y, Chien Y (2006) Gamma delta T cells - innate immune lymphocytes? Curr Opin Immunol 18:527-533
42. Kuo J, Douglas M, Ree HK, Lindberg AA (1995) Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines. Infect Immun 63:2706-2713
43. Landers CD, Bondada S (2005) CpG oligodeoxynucleotides stimulate cord blood mononuclear cells to produce immunoglobulins. Clin Immunol 116:236-245
44. Latz E, Franko J, Golenbock DT, Schreiber JR (2004) Haemophilus influenzae type b-outer membrane protein complex glyco-conjugate vaccine induces cytokine production by engaging human toll-like receptor (TLR2) and requires TLR2 for optimal immunogenicity. J Immunol 172:2431-2438
45. Lee CY, Lee JC (2000) Staphylococcal capsule. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI (eds) Gram-positive pathogens. ASM Press, Washington DC, pp 361-366
46. Lee JC (1996) The prospects for developing a vaccine against Staphylococcus aureus. Trends Microbiol 4:162-166
47. Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111:1265-1273
48. MacLennan JC, Toellner KM, Cunningham AF, Serre K, Sze DM (2003) Extra follicular antibody responses. Immunol Rev 194:8-18
49. Malissein E, Verdier M, Ratinaud MH, Troutaud D (2006) Activation of Bad trafficking is involved in the BCR-mediated apoptosis of immature B cells. Apoptosis 11:1003-1012
50. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Goldenbock DT (2003) Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A 100:1966-1971
51. Martin F, Kearney JF (2002) Marginal zone B cells. Nat Rev Immunol 2:323-335
52. Mattner J, Bebord KL, Ismail N, Goff RD, Cantu C, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525-529
53. Mawas F, Dickinson R, Douglas-Bardsley A, Xing DK, Sesardic D, Corbel MJ (2006) Immune interaction between components of acellular pertussis-diphtheria- tetanus (DTaP) and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model. Vaccine 24:3505-3512
54. McVernon J, Mitchison NA, Moxon ER (2004) T helper cells and efficacy of Haemophilus influenzae type b conjugate vaccination. Lancet Infect Dis 4:40-43
55. Merck (2005) Pneumovax 23® (Pneumococcal vaccine polyvalent). Product circular, 7999825
56. Merck (2006) PedvaxHIB® Haemophilus b conjugate vaccine (www.merckvaccines.com/vaccines/haem/index.html)
57. Miller MJ, Wei SH, Parker I, Cahalan MD (2002) Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 296:1869-1873
58. Mitchison NA (2004) T-cell-B-cell cooperation. Nat Rev Immunol 4:308-312
59. Mond JJ, Sehgal E, Sachs DH, Paul WE (1979a) Expression of 1a antigen on adult and neonatal B lymphocytes responsive to thymus-independent antigens. J Immunol 123:1619-1623
60. Mond JJ, Stein KE, Subbarao B, Paul WE (1979b) Analysis of B cell activation requirements with TNP-conjugated polyacrylamide beads. J Immunol 123:239-245
61. Mond JJ, Farrar J, Paul WE, Fuller-Farrar J, Schaeffer M, Howard M (1983) T cell dependence and factor reconstitution of In vitro antibody responses to TNP-B. abortus and TNP-ficoll: restoration of depleted responses with chromatographed fractions of a T cell-derived factor. J Immunol 131:633-637
62. Mond JJ, Lees A, Snapper CM (1995) T cell-independent antigens type 2. Ann Rev Immunol 13:655-692
63. Mosier DE, Mond JJ, Goldings EA (1977) The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with X-linked B cell defect. J Immunol 119:1874-1878
64. Neuhaus FC, Baddiley J (2003) A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in Gram-positive bacteria. Microbiol Molec Biol Rev 67:686-723
65. Niiro H, Clark EA (2002) Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2:945-956
66. Peeters CC, Tenbergen-Meekes AM, Poolman JT, Beurret M, Zegers BJ, Rikers GT (1991) Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines. Infect Immun 59:3504-3510
67. Poolman JT, Bakaletz L, Cripps A, Denoel PA, Forsgren A, Kyd J, Lobet Y (2000) Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine 19:S108-S115
68. Pozdnyakova O, Guttormsen HK, Lalani FN, Carroll MC, Kasper DL (2003) Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice. J Immunol 170:84-90
69. Region-of-Waterloo-Public-Health (2004) Fact sheet for Menjugate® (meningococcal-C vaccine). DOCS, 152595
70. Riordan KO, Lee JC (2004) Staphylococcus aureus capsular polysaccharide. Clin Microbiol Rev 17:218-234
71. Robbins JB, Schneerson R (1990) Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D. N Engl J Med 323:1415-1416
72. Ruggeberg JU, Pollard AJ (2004) Meningococcal vaccines. Pediatr Drugs 6:251-266
73. Sanofi-Pasteur (2005a) Haemophilus b conjugate vaccine ActHIB®. Product insert, 095 3105021
74. Sanofi-Pasteur (2005b) Typhim Vi®, Vi capsular polysaccharide typhoid vaccine. Patient information leaflet, 17387
75. Sanofi-Pasteur (2006) Meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine, Menactra®. Prescribing information, 284 3108234
76. Sater RA, Sandel PC, Monroe JG (1998) B cell receptor-induced apoptosis in primary transitional murine B cells: signaling requirements and modulation by T cell help. Int Immunol 10:1673-1682
77. Scher I, Steinberg AD, Berning AK, Paul WE (1975) X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect. J Exp Med 142:637-650
78. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ (1999) Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274:17406-17409
79. Sen G, Khan AQ, Chen Q, Snapper CM (2005) In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands. J Immunol 175:3084-3091
80. Sidman CL, Unanue ER (1975) Receptor-mediated inactivation of early B lymphocytes. Nature 257:149-151
81. Snapper CM, Mond JJ (1996) A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J Immunol 157:2229-2233
82. Snapper CM, Shen Y, Khan AQ, Colino J, Zelazowski P, Mond JJ, Gause WC, Wu ZQ (2001) Distinct types of T-cell help for the induction of a humoral immune response to Streptococcus pneumoniae. Trends Immunol 22:308-311
83. Sproul TW, Malapati S, Kim J, Pierce SK (2000) Cutting edge: B cell antigen receptor signaling occurs outside lipid rafts in immature B cells. J Immunol 165:6020-6023
84. Sverremark E, Fernandez C (1998) Role of T cells and germinal center formation in the generation of immune responses to the thymus-independent carbohydrate dextran B512. J Immunol 161:4646-4651
85. Treiner E, Lantz O (2006) CD1d- and MR1-resticted invariant T cells: of mice and men. Curr Opin Immunol 18:519-526
86. Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ (2000) B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev 176:154-170
87. Weidenmaier C, Kokai-Kun JF, Kristian SA, Chanturiya T, Kalbacher H, Gross M, Nicholson G, Neumeister B, Mond JJ, Peschel A (2004) Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nature Med 10:243-245
88. Weintraub BC, Jun JE, Bishop AC, Shokat KM, Thomas ML, Goodnow CC (2000) Entry of B cell receptor into signaling domains is inhibited in tolerant B cells. J Exp Med 191:1443-1448
89. Whitney CG (2005) Impact of conjugate pneumococcal vaccines. Pediatr Infect Dis J 24:729-730
90. Wu ZQ, Vos Q, Shen Y, Lees A, Wilson SR, Briles DE, Gause WC, Mond JJ, Snapper CM (1999) In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions. J Immunol 163:659-667
91. Wu ZQ, Khan AQ, Shen Y, Schartman J, Peach R, Lees A, Mond JJ, Gause WC, Snapper CM (2000) B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae. J Immunol 165:6840-3848
92. Wyeth (2005) Haemophilus b conjugate vaccine HibTITER®. Product insert, W10461C004
93. Wyeth (2006) Pneumococcal 7-valent conjugate vaccine (diphtheria CRM 197 protein) Prevnar®. Prescribing information, W10430C006
94. Wyeth-Australia (2005) Meningitec® Meningococcal Group C Conjugate Vaccine. Consumer medicine information, AUST R 75721
95. Zarember KA, Godowski PJ (2002) Tissue expression of human TLR and differential regulation of TLR mRNA's in leukocytes in response to microbes, their products, and cytokines. J Immunol 168:554-561